Guggenheim Capital’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-58,530
| Closed | -$353K | – | 2084 |
|
|
2019
Q4 | $353K | Buy |
+58,530
| New | +$353K | ﹤0.01% | 1753 |
|
|
2017
Q2 | – | Sell |
-11,987
| Closed | -$50K | – | 2891 |
|
|
2017
Q1 | $50K | Sell |
11,987
-3,538
| -23% | -$14.8K | ﹤0.01% | 2735 |
|
|
2016
Q4 | $64K | Sell |
15,525
-278,317
| -95% | -$1.15M | ﹤0.01% | 2792 |
|
|
2016
Q3 | $2.38M | Buy |
293,842
+15,621
| +6% | +$127K | 0.01% | 1506 |
|
|
2016
Q2 | $2.17M | Sell |
278,221
-50,820
| -15% | -$396K | 0.01% | 1511 |
|
|
2016
Q1 | $2.54M | Sell |
329,041
-86,798
| -21% | -$670K | 0.01% | 1416 |
|
|
2015
Q4 | $4.49M | Sell |
415,839
-218,159
| -34% | -$2.35M | 0.01% | 1066 |
|
|
2015
Q3 | $4.38M | Buy |
633,998
+290,066
| +84% | +$2M | 0.01% | 1112 |
|
|
2015
Q2 | $3.05M | Buy |
343,932
+274,090
| +392% | +$2.43M | 0.01% | 1444 |
|
|
2015
Q1 | $688K | Sell |
69,842
-263,239
| -79% | -$2.59M | ﹤0.01% | 2409 |
|
|
2014
Q4 | $4.08M | Buy |
333,081
+76,445
| +30% | +$936K | 0.01% | 1234 |
|
|
2014
Q3 | $2.56M | Buy |
+256,636
| New | +$2.56M | 0.01% | 1568 |
|
|
2014
Q2 | – | Sell |
-10,015
| Closed | -$33K | – | 3266 |
|
|
2014
Q1 | $33K | Sell |
10,015
-1,222
| -11% | -$4.03K | ﹤0.01% | 3123 |
|
|
2013
Q4 | $37K | Sell |
11,237
-358,576
| -97% | -$1.18M | ﹤0.01% | 3021 |
|
|
2013
Q3 | $1.12M | Sell |
369,813
-129,591
| -26% | -$391K | ﹤0.01% | 1986 |
|
|
2013
Q2 | $4.09M | Buy |
+499,404
| New | +$4.09M | 0.02% | 1145 |
|